BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3317919)

  • 1. [Clinical trails of piroxicam suppositories in the therapy of rheumatoid arthritis].
    Iwata H; Nakajima M; Nobenaga T
    Ryumachi; 1987 Apr; 27(2):147-55. PubMed ID: 3317919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Piroxicam in the treatment of rheumatoid arthritis].
    Murav'ev IuV; Mamistova AI; Sigidin IaA
    Ter Arkh; 1988; 60(4):128-30. PubMed ID: 3293252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study].
    Myklebust G
    Tidsskr Nor Laegeforen; 1986 Jun; 106(17-18):1485-7. PubMed ID: 3532419
    [No Abstract]   [Full Text] [Related]  

  • 4. Piroxicam suppositories for osteoarthritis and rheumatoid arthritis: an open multicentre study in 116 patients.
    Heynen G; Dessain P
    Eur J Rheumatol Inflamm; 1983; 6(1):134-8. PubMed ID: 6345164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic action of Piroxicam administered rectally in rheumatic diseases. Controlled double-blind study].
    Maccà F; Milani L; Dal Follo M; Corbetta L; Zeni G; Zuin R
    Minerva Med; 1984 Apr; 75(14-15):811-9. PubMed ID: 6374502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piroxicam versus naproxen in rheumatoid arthritis: a double-blind, cross-over study.
    Larsen A
    Int J Clin Pharmacol Res; 1985; 5(1):17-23. PubMed ID: 3888863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of pirprofen (rengasil) combined with maintenance doses of corticosteroids in rheumatoid arthritis in a double-blind multicenter trial].
    Trofimova TM; Alekberova ZS; Pokryshkin VI; Kobaladze SG; Taletene IP
    Ter Arkh; 1986; 58(7):95-7. PubMed ID: 3532404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, crossover, multicentre study of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
    Finstad R
    Br J Clin Pract; 1981 Jan; 35(1):35-9. PubMed ID: 7020731
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of piroxicam in rheumatoid arthritis by double blind comparative multi-center studies].
    Ryumachi; 1980 Jun; 20(3):220-8. PubMed ID: 6998024
    [No Abstract]   [Full Text] [Related]  

  • 10. A double blind cross-over comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
    Davies J; Dixon AS; Ring EF
    Eur J Rheumatol Inflamm; 1981; 4(3):314-7. PubMed ID: 6242952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Steady-state plasma levels of piroxicam of 4 different origins and relation to clinical effects in the treatment of rheumatoid arthritis].
    Pavelka K; Pavelka K; Pelísková Z; Macek J; Lichý A; Trnavský K
    Cas Lek Cesk; 1988 Jul; 127(29):905-8. PubMed ID: 3048694
    [No Abstract]   [Full Text] [Related]  

  • 12. [A controlled double-blind clinical trial of ketoprofen suppository in rheumatoid arthritis (author's transl)].
    Shichikawa K; Nobunaga T; Iwasaki T
    Ryumachi; 1982 Apr; 22(2):185-95. PubMed ID: 7051362
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind comparison of piroxicam and enteric coated ASA in rheumatoid arthritis. A Cooperative Multicenter Canadian trial.
    J Rheumatol; 1985 Feb; 12(1):68-77. PubMed ID: 3884806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
    Domljan Z; Durrigl T
    Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac and piroxicam in a double-blind trial results and methodological problems. Working Party of the Society for Rheumatology of the GDR for the Testing of Anti-rheumatic Drugs.
    Keitel W; Friedländer R; Häntzschel H; Hüge W; Keysser M; Seidel W; Tanner E; Wächter G; Weber J; Wille R
    Eur J Rheumatol Inflamm; 1984; 7(3):105-13. PubMed ID: 6400520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of diflunisal and piroxicam in the management of patients with rheumatoid arthritis.
    Rice DM
    Clin Ther; 1987; 10(1):92-7. PubMed ID: 3329968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind evaluation of piroxicam and naproxen following missed dosage in patients with inflammatory arthritis.
    Langley GB; Fowles M; Sirett P; Vlieg M; Wigley RD
    N Z Med J; 1985 Jun; 98(781):490-2. PubMed ID: 3892383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.
    Chlud K; Pangerl S
    Pharmatherapeutica; 1985; 4(2):113-21. PubMed ID: 3903778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis.
    Havranek H
    Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.